|
|
|
Volumn 164, Issue 1, 2001, Pages
|
|
Thioridazine (Mellaril) and mesoridazine (Serentil): prolongation of the QTc interval.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MESORIDAZINE;
NEUROLEPTIC AGENT;
THIORIDAZINE;
ARTICLE;
DRUG CONTRAINDICATION;
DRUG EFFECT;
HEART ARRHYTHMIA;
HEART MUSCLE CONDUCTION SYSTEM;
HUMAN;
LONG QT SYNDROME;
SCHIZOPHRENIA;
ANTIPSYCHOTIC AGENTS;
ARRHYTHMIA;
HEART CONDUCTION SYSTEM;
HUMANS;
LONG QT SYNDROME;
MESORIDAZINE;
SCHIZOPHRENIA;
THIORIDAZINE;
|
|
EID: 0035830474
PISSN: 08203946
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (13)
|
|
References (0)
|
